Role of vascular remodeling markers in the development of osteoporosis in idiopathic pulmonary arterial hypertension
- Authors: Nevzorova VA1, Kochetkova EA1, Ugay LG1, Maistrovskaya Y.V1, Khludeeva EA1
-
Affiliations:
- Тихоокеанский государственный медицинский университет Минздрава России
- Issue: Vol 88, No 9 (2016)
- Pages: 65-70
- Section: Editorial
- URL: https://journals.rcsi.science/0040-3660/article/view/32076
- DOI: https://doi.org/10.17116/terarkh201688965-70
- ID: 32076
Cite item
Full Text
Abstract
About the authors
V A Nevzorova
Тихоокеанский государственный медицинский университет Минздрава РоссииВладивосток, Россия
E A Kochetkova
Тихоокеанский государственный медицинский университет Минздрава РоссииВладивосток, Россия
L G Ugay
Тихоокеанский государственный медицинский университет Минздрава РоссииВладивосток, Россия
Yu V Maistrovskaya
Тихоокеанский государственный медицинский университет Минздрава РоссииВладивосток, Россия
E A Khludeeva
Тихоокеанский государственный медицинский университет Минздрава РоссииВладивосток, Россия
References
- Wang TK, O’Sullivan S, Gamble GD, Ruygrok PN. Bone density in heart or lung transplant recipients — a longitudinal study. Transplant Proc. 2013;45(6):2357-2365. doi: 10.1016/j.transproceed.2012.09.117
- Global Initiative for Chronic Obstructive Lung Disease (updated 2016).http://www.goldcopd.org/uploads/users/files/WatermarkedGlobal_20Strategy_202016(1).pdf
- GINA Report, Global Strategy for Asthma Management and Prevention. http://ginasthma.org/gina-report-global-strategy-for-asthma-management-and-prevention/
- Bon JM, Zhang Y, Duncan SR, Pilewski JM, Zaldonis D, Zeevi A, McCurry KR, Greenspan SL, Sciurba FC. Plasma inflammatory mediators associated with bone metabolism in COPD. COPD. 2010;7:186-191. doi: 10.3109/15412555.2010.482114
- Vrieze A, de Greef MH, Wijkstra PJ, Wempe JB. Low bone mineral density in COPD patients related to worse lung function, low weight and decreased fat-free mass. Osteoporos Int. 2007;18(9):1197-1202.
- Franco CB, Paz-Filho G, Gomes PE, Nascimento VB, Kulak CA, Boguszewski CL, Borba VZ. Chronic obstructive pulmonary disease is associated with osteoporosis and low levels of vitamin D. Osteoporos Int. 2009;20:1881-1887. doi: 10.1007/s00198-009-0890-5
- Katsura H, Kida K. A comparison of bone mineral density in elderly female patients with COPD and bronchial asthma. Chest. 2002;122:1949-1955.
- Мартынюк Т.В., Чазова И.Е. Новые возможности в стратегии лечения больных с идиопатической легочной гипертензией: антагонист рецепторов эндотелина бозентан. Системные гипертензии. 2008;4:25-36. http://www.gipertonik.ru/files/journals/SG4(2008).pdf
- Galiè N, Humbert M, Vachiery JL, Gibbs S, Lang I et al. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). Eur Heart J. 2016;37(1):67-119. doi: 10.1093/eurheartj/ehv317
- Tschopp O, Schmid C, Speich R, Seifert B, Russi EW, Boehler A. Pretransplantation bone disease in patients with primary pulmonary hypertension. Chest. 2006;129:1002-1008.
- Malik N, McCarthy K, Minai OA. Prevalence and significance of decreased bone density in pulmonary arterial hypertension. South Med J. 2012;105(7):344-349. doi: 10.1097/SMJ.0b013e31825b8117
- Peled N, Shitrit D, Fox BD, Shlomi D, Amital A, Bendayan D, Kramer MR. Peripheral arterial stiffness and endothelial dysfunction in idiopathic and scleroderma associated pulmonary arterial hypertension. J Rheumatol. 2009;36(5):970-975. doi: 10.3899/jrheum.081088
- Safdar Z, Tamez E, Frost A, Guffey D, Minard CG, Entman ML. Collagen Metabolism Biomarkers and Health Related Quality of Life in Pulmonary Arterial Hypertension. Int J Cardiovasc Res. 2015;4(2). doi: 10.4172/2324-8602.1000198
- Alangiakrishman K, Juby A, Hanley D, Tymchak W, Sclater A. Role of vascular factors in osteoporosis. J Gerontol: Med Scie. 2003;58(4):362-366.
- Sumino H, Ichikawa S, Kasama S et al. Relationship between brachial arterial endothelial function and lumbar spine bone mineral density in postmenopausal women. Circulation J. 2007;71(10):1555-1559. doi: 10.1253/circj.71.1555
- Prasad M, Reriani M, Khosla S, Gössl M, Lennon R, Gulati R, Prasad A, Lerman LO, Lerman A. Coronary microvascular endothelial dysfunction is an independent predictor of development of osteoporosis in postmenopausal women. Vasc Health Risk Manag. 2014;10:533-538. doi: 10.2147/VHRM.S63580
- Delgado-Frías E, López-Mejias R, Genre F, Ubilla B, Gómez Rodríguez-Bethencourt MA, González-Díaz A, de Vera-González AM, González-Rivero AF, Díaz-González F, González-Gay MA, Ferraz-Amaro I. Relationship between endothelial dysfunction and osteoprotegerin, vitamin D, and bone mineral density in patients with rheumatoid arthritis. Clin Exp Rheumatol. 2015;33(2):241-249.
- Madonna R, Novo G, Balistreri CR. Cellular and molecular basis of the imbalance between vascular damage and repair in aging and age-related diseases: As biomarkers and targets for new treatments. Mech Ageing Dev. 2016 Mar 15. pii: S0047-6374(16)30026-4. doi: 10.1016/j.mad.2016.03.005
- Clarkin CE, Gerstenfeld LC. VEGF and bone cell signalling: an essential vessel for communication? Cell Biochem Funct. 2013;31(1):1-11. doi: 10.1002/cbf.2911
- Wang XM, Shi K, Li JJ, Chen TT, Guo YH, Liu YL, Yang YF, Yang S. Effects of angiotensin II intervention on MMP-2, MMP-9, TIMP-1, and collagen expression in rats with pulmonary hypertension. Genet Mol Res. 2015;14(1):1707-1717. doi: 10.4238/2015.March.6.17
- Pardo A, Cabrera S, Maldonado M, Selman M. Role of matrix metalloproteinases in the pathogenesis of idiopathic pulmonary fibrosis. Respir Res. 2016;17(1):23. doi: 10.1186/s12931-016-0343-6
- Schumann C, Lepper PM, Frank H, Schneiderbauer R, Wibmer T, Kropf C, Stoiber KM, Rüdiger S, Kruska L, Krahn T, Kramer F. Circulating biomarkers of tissue remodelling in pulmonary hypertension. Biomarkers. 2010;15(6):523-532. doi: 10.3109/1354750X.2010.492431
- Jiang L, Zhou T, Liu H. Combined effects of the ATP-sensitive potassium channel opener pinacidil and simvastatin on pulmonary vascular remodeling in rats with monocrotaline-induced pulmonary arterial hypertension. Pharmazie. 2012;67(6):547-552.
- Невзорова В.А., Тилик Т.В., Гилифанов Е.А., Панченко Е.А., Вахрушева С.Е., Тилик В.В. Роль матриксных металлопротеиназ в формировании морфофункционального дисбаланса воздухоносных путей при хронической обструктивной болезни легких. Тихоокеанский медицинский журнал. 2011;2:9-13. Доступно по: http://www.tmj-vgmu.ru/files/old/PMJ_2009-2011/1509.pdf
- Bergers G, Brekken R, McMahon G, Vu TH, Itoh T, Tamaki K, Tanzawa K, Thorpe P, Itohara S, Werb Z, Hanahan D. Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis. Nat Cell Biol. 2000;2(10):737-744.
- Anderson TL, del Carem Ovejero M, Kirkegaard T et al. A scrutiny of matrix metalloproteinases in osteoclasts: evidence for heterogeneity and for the presence of MMPs synthesized by other cells. Bone. 2004;35:1107-1119.
- Li Y, Zhang Zh, Xu Yo et al. TNF-α Up-regulates Matrix Metalloproteinase-9 Expression and Activity in Alveolar Macrophages from Patients with Chronic Obstructive Pulmonary Disease. J Huazhong University of Science and Technology 2006;26(6):647-650. doi:10.1007/s 11596-006-0604-6
- Song H, Cheng Y, Bi G, Zhu Y, Jun W, Ma W, Wu H. Release of Matrix Metalloproteinases-2 and 9 by S-Nitrosylated Caveolin-1 Contributes to Degradation of Extracellular Matrix in tPA-Treated Hypoxic Endothelial Cells. PLoS One. 2016;11(2):e0149269. doi: 10.1371/journal.pone.0149269
- Safdar Z, Tamez E, Chan W, Arya B, Ge Y, Deswal A, Bozkurt B, Frost A, Entman M. Circulating collagen biomarkers as indicators of disease severity in pulmonary arterial hypertension. JACC Heart Fail. 2014;2(4):412-421. doi: 10.1016/j.jchf.2014.03.013
- Benza RL, Gomberg-Maitland M, Demarco T, Frost AE, Torbicki A, Langleben D, Pulido T, Correa-Jaque P, Passineau MJ, Wiener HW, Tamari M, Hirota T, Kubo M, Tiwari HK. Endothelin-1 Pathway Polymorphisms and Outcomes in Pulmonary Arterial Hypertension. Am J Respir Crit Care Med. 2015;192(11):1345-1354. doi: 10.1164/rccm.201501-0196OC
- Serizawa K, Yogo K, Tashiro Y, Takeda S, Kawasaki R, Aizawa K, Endo K. Eldecalcitol prevents endothelial dysfunction in postmenopausal osteoporosis model rats. J Endocrinol. 2016;228(2):75-84. doi: 10.1530/JOE-15-0332
- Mestek ML, Weil BR, Greiner JJ, Westby CM, DeSouza CA, Stauffer BL. Osteopenia and endothelin-1-mediated vasconstrictor tone in postmenopausal women. Bone. 2010;47(3):542-545. doi: 10.1016/j.bone.2010.05.041
![](/img/style/loading.gif)